menuBe part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  • ESC 2024 Image
    Medical News

    Pooled analysis shows finerenone reduces cardio-kidney outcomes in CKM syndrome

  • ESC 2024 Image
    Medical News

    Finerenone reduces CV death or total HF events in patients with HFmrEF or HFpEF

  • ESC 2024 Image
    Medical News

    No difference in MACE risk with evening versus morning dosing of antihypertensi…

Programs

  • Class I recommendation to use the AF-CARE pathway in new ESC guidelines for AF
    ESC Action Center

    Class I recommendation to use the AF-CARE pathway in new ESC guidelines for AF

  • Monitoring and Managing Treatment-Related Adverse Effects Associated With HER2-…
    MinuteCE®

    Monitoring and Managing Treatment-Related Adverse Effects Associated With HER2-Directed Agents

    0.75 program credits
  • A Deep Dive into the Pathophysiology of CAH and Its Impact on Treatment
    Clinician's Roundtable

    A Deep Dive into the Pathophysiology of CAH and Its Impact on Treatment

  • Patient-Centric Tools to Support Shared Decision-Making: Diagnosing and Assessi…
    CME/CE

    Patient-Centric Tools to Support Shared Decision-Making: Diagnosing and Assessing Endometriosis 

    0.25 credits
  • Risk-Stratification in Newly Diagnosed CLL
    MinuteCE®

    Risk-Stratification in Newly Diagnosed CLL

    1.25 program credits
  • Recommendations on the management of HCM in guidelines: European vs. American v…
    MinuteCE®

    Recommendations on the management of HCM in guidelines: European vs. American views

    0.75 program credits

Clinical Practice

  • Staying Up to Date with Travel Vaccination Recommendations
    VacciNation

    Staying Up to Date with Travel Vaccination Recommendations

  • Optimizing HCC Screening: Strategies to Overcome Common Barriers
    Project Oncology®

    Optimizing HCC Screening: Strategies to Overcome Common Barriers

  • Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Ti…
    MinuteCE®

    Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time

    1.00 program credits
  • Case in Point: The Use of GnRH Antagonists Pre- and/or Post-Surgery and the Pot…
    CME/CE

    Case in Point: The Use of GnRH Antagonists Pre- and/or Post-Surgery and the Potential Consequences of Repeat Surgery 

    0.50 credits
  • Risk Assessment in Pulmonary Hypertension: Practice Trends and Updates
    CME/CE Live Broadcast

    September 12, 2024

    01:00 PM - 02:00 PM EDT

    Risk Assessment in Pulmonary Hypertension: Practice Trends and Updates

  • Emerging Data Evaluating HER2-Directed Therapies in Gynecologic Cancers
    MinuteCE®

    Emerging Data Evaluating HER2-Directed Therapies in Gynecologic Cancers

    0.75 program credits

Doctors Lounge

  • Op-Ed: Workplace Burnout and Physician/Medical Student Well-Being
    Op-Ed

    Op-Ed: Workplace Burnout and Physician/Medical Student Well-Being

  • Improving Outcomes and Addressing Racial Disparities in Patients With HR+/HER2-…
    CME/CE

    Improving Outcomes and Addressing Racial Disparities in Patients With HR+/HER2- Early Breast Cancer: A Case-Based Learning Lab 

    0.25 credits
  • KOL Knockout™: Cancer Pain Management Edition
    CME/CE

    KOL Knockout™: Cancer Pain Management Edition

    1.50 credits
  • Partners in Medicine: A Married Couple's Adventure in Locum Tenens
    Spotlight on Locum Tenens

    Partners in Medicine: A Married Couple's Adventure in Locum Tenens

  • Study: Psoriasis Patients with Skin of Color Wait 3x Longer for Diagnosis
    On the Frontlines of Psoriasis

    Study: Psoriasis Patients with Skin of Color Wait 3x Longer for Diagnosis

  • Cultural and Aesthetic Considerations in Patients with Skin of Color
    Practical Dermatology

    Cultural and Aesthetic Considerations in Patients with Skin of Color

CME

  • Patient Case: How Do HER2-Directed Therapies Fit Into the Ovarian Cancer Treatm…
    MinuteCE®

    Patient Case: How Do HER2-Directed Therapies Fit Into the Ovarian Cancer Treatment Landscape?

    0.75 program credits
  • Macitentan Update: Impact on Management of Pulmonary Hypertension
    MinuteCE®

    Macitentan Update: Impact on Management of Pulmonary Hypertension

    1.00 program credits
  • Challenges of managing hyperkalemia in patients with cardiorenal disease while …
    MinuteCE®

    Challenges of managing hyperkalemia in patients with cardiorenal disease while maintaining RAASi therapy 

    0.75 program credits
  • Changing the Paradigm in the Management of Endometriosis: Moving Away From “Sur…
    MinuteCE®

    Changing the Paradigm in the Management of Endometriosis: Moving Away From “Surgery First” to “Pharmacologic Therapy First”

    1.75 program credits
  • Diversity in HER2 Expression Among Gynecologic Cancers
    MinuteCE®

    Diversity in HER2 Expression Among Gynecologic Cancers 

    0.75 program credits
  • Pre- and Postoperative Use of GnRH Antagonists
    MinuteCE®

    Pre- and Postoperative Use of GnRH Antagonists

    1.75 program credits

Industry Feature

  • Recognizing Agitation in Alzheimer’s Dementia: Screening Tool for Caregivers
    Medical Industry Feature

    Recognizing Agitation in Alzheimer’s Dementia: A Screening Tool for Caregivers

  • Beyond Symptom Control: Treating the Root Cause of House Dust Mite Allergies
    Medical Industry Feature

    Beyond Symptom Control: Treating the Root Cause of House Dust Mite Allergies

  • Macular Edema Following Retinal Vein Occlusion: Patient Case and Safety Data
    Medical Industry Feature

    Macular Edema Following Retinal Vein Occlusion: Patient Case and Safety Data

  • Macular Edema Following Retinal Vein Occlusion: Phase III Clinical Trial Outcom…
    Medical Industry Feature

    Macular Edema Following Retinal Vein Occlusion: Phase III Clinical Trial Outcomes

  • Pathophysiology and Treatment of Macular Edema Following Retinal Vein Occlusion
    Medical Industry Feature

    Pathophysiology and Treatment of Macular Edema Following Retinal Vein Occlusion

  • Exploring an Option to Help Manage Recovery From Neuromuscular Blockade
    Medical Industry Feature

    Exploring an Option to Help Manage Recovery From Neuromuscular Blockade

Schedule1 Sep 2024